OpenAlex
PricingAboutJobs
Log inGet started
Work

Preclinical and clinical development of the oral multikinase inhibitor sorafenib in cancer treatment

HTML

Year: 2005
Type: article
Source: Drugs of today
DOI: 10.1358/dot.2005.41.12.937959
Author: Strumberg, D.
Institution: Universitätsklinik Marien Hospital Herne
Language: English

Topic: Angiogenesis and VEGF in Cancer
Subfield: Molecular Biology
Field: Biochemistry, Genetics and Molecular Biology
Domain: Life Sciences
Keywords: sorafenib, multikinase inhibitor, Ras/Raf signaling, tumor angiogenesis, VEGFR2, VEGFR-3, PDGFRβ, FLT3, CD117, renal cell carcinoma, hepatocellular carcinoma, sarcoma, metastatic melanoma, colon cancer, breast cancer, non-small cell lung cancer, progression-free survival, drug safety
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W2047964609
FWCI: 5.265
Cites:
Cited by: 211
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms